Molecular surveillance of drug-resistant Plasmodium falciparum in two distinct geographical areas of Nigeria
详细信息 查看全文
- 作者：Olusola Ojurongbe (1) (2)
Segun I. Oyedeji (2) (4)
Wellington A. Oyibo (3)
Adetola F. Fagbenro-Beyioku (3)
Jürgen F. Kun (1) - 关键词：Malaria ; Drug resistance ; Real time PCR ; Nigeria
- 刊名：Wiener klinische Wochenschrift
- 出版年：2010
- 出版时间：December 2010
- 年：2010
- 卷：122
- 期：23-24
- 页码：681-685
- 全文大小：182KB
- 参考文献：1. WHO (2005) World Malaria Report. Geneva
2. FMOH (2005) Federal Republic of Nigeria National antimalarial treatment policy. Abuja: Federal Ministry of Health
3. Talisuna AO, Bloland P, D'Alessandro U. History, dynamics, and public health importance of malaria parasite resistance. Clin Microbiol Rev 2004;17:235-4 i.org/10.1128/CMR.17.1.235-254.2004">CrossRef
4. Fidock DA, Nomura T, Talley AK, Cooper RA, Dzekunov SM, et al. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol Cell 2000;6:861-1 i.org/10.1016/S1097-2765(05)00077-8">CrossRef
5. Sidhu AB, Verdier-Pinard D, Fidock DA. Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by pfcrt mutations. Science 2002;298:210- i.org/10.1126/science.1074045">CrossRef
6. Reed MB, Saliba KJ, Caruana SR, Kirk K, Cowman AF. Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum. Nature 2000;403:906- i.org/10.1038/35002615">CrossRef
7. Chen N, Kyle DE, Pasay C, Fowler EV, Baker J, et al. pfcrt Allelic types with two novel amino acid mutations in chloroquine-resistant Plasmodium falciparum isolates from the Philippines. Antimicrob Agents Chemother 2003;47:3500-5 i.org/10.1128/AAC.47.11.3500-3505.2003">CrossRef
8. Durrand V, Berry A, Sem R, Glaziou P, Beaudou J, et al. Variations in the sequence and expression of the Plasmodium falciparum chloroquine resistance transporter (Pfcrt) and their relationship to chloroquine resistance in vitro. Mol Biochem Parasitol 2004;136:273-5 i.org/10.1016/j.molbiopara.2004.03.016">CrossRef
9. Mehlotra RK, Fujioka H, Roepe PD, Janneh O, Ursos LM, et al. Evolution of a unique Plasmodium falciparum chloroquine-resistance phenotype in association with pfcrt polymorphism in Papua New Guinea and South America. Proc Natl Acad Sci USA 2001;98:12689-4 i.org/10.1073/pnas.221440898">CrossRef
10. Keen J, Farcas GA, Zhong K, Yohanna S, Dunne MW, et al. Real-time PCR assay for rapid detection and analysis of PfCRT haplotypes of chloroquine-resistant Plasmodium falciparum isolates from India. J Clin Microbiol 2007;45:2889-3 i.org/10.1128/JCM.02291-06">CrossRef
11. Price RN, Cassar C, Brockman A, Duraisingh M, van Vugt M, et al. The pfmdr1 gene is associated with a multidrug-resistant phenotype in Plasmodium falciparum from the western border of Thailand. Antimicrob Agents Chemother 1999;43:2943-9
12. Duraisingh MT, Jones P, Sambou I, von Seidlein L, Pinder M, et al. The tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum is associated with increased sensitivity to the anti-malarials mefloquine and artemisinin. Mol Biochem Parasitol 2000;108:13-3 i.org/10.1016/S0166-6851(00)00201-2">CrossRef
13. Plowe CV, Roper C, Barnwell JW, Happi CT, Joshi HH, et al. World Antimalarial Resistance Network (WARN) III: molecular markers for drug resistant malaria. Malar J 2007;6:121-0 i.org/10.1186/1475-2875-6-121">CrossRef
14. Brooks DR, Wang P, Read M, Watkins WM, Sims PF, et al. Sequence variation of the hydroxymethyldihydropterin pyrophosphokinase: dihydropteroate synthase gene in lines of the human malaria parasite, Plasmodium falciparum, with differing resistance to sulfadoxine. Eur J Biochem 1994;224:397-05 i.org/10.1111/j.1432-1033.1994.00397.x">CrossRef
15. Basco LK. Molecular epidemiology of malaria in Cameroon. XII. In vitro drug assays and molecular surveillance of chloroquine and proguanil resistance. Am J Trop Med Hyg 2002;67:383-
16. Ojurongbe O, Ogungbamigbe TO, Fagbenro-Beyioku AF, Fendel R, Kremsner PG, et al. Rapid detection of Pfcrt and Pfmdr1 mutations in Plasmodium falciparum isolates by FRET and in vivo response to chloroquine among children from Osogbo, Nigeria. Malar J 2007;6:41- i.org/10.1186/1475-2875-6-41">CrossRef
17. Ogungbamigbe TO, Ojurongbe O, Ogunro PS, Okanlawon BM, Kolawole SO Chloroquine resistant Plasmodium falciparum malaria in Osogbo Nigeria: efficacy of amodiaquine + sulfadoxine-pyrimethamine and chloroquine + chlorpheniramine for treatment. Mem Inst Oswaldo Cruz 2008;103:79-4 i.org/10.1590/S0074-02762008000100012">CrossRef
18. Bruce-Chwatt LJ. Malaria in Nigeria. Bull World Health Organ 1951;4:301-7
19. Duraisingh MT, Cowman AF. Contribution of the pfmdr1 gene to antimalarial drug-resistance. Acta Trop 2005;94:181-0
20. Duraisingh MT, Roper C, Walliker D, Warhurst DC. Increased sensitivity to the antimalarials mefloquine and artemisinin is conferred by mutations in the pfmdr1 gene of Plasmodium falciparum. Mol Microbiol 2000;36:955-1 i.org/10.1046/j.1365-2958.2000.01914.x">CrossRef
21. Sisowath C, Stromberg J, Martensson A, Msellem M, Obondo C, et al. In vivo selection of Plasmodium falciparum pfmdr1 86N coding alleles by artemether-lumefantrine (Coartem). J Infect Dis 2005;191:1014- i.org/10.1086/427997">CrossRef
22. Hastings I, Ward S. Coartem (artemether-lumefantrine) in Africa: the beginning of the end? J Infect Dis 2005;192:1290- i.org/10.1086/432554">CrossRef
23. Price RN, Uhlemann AC, van Vugt M, Brockman A, Hutagalung R, et al. Molecular and pharmacological determinants of the therapeutic response to artemether-lumefantrine in multidrug-resistant Plasmodium falciparum malaria. Clin Infect Dis 2006;42:1570- i.org/10.1086/503423">CrossRef
24. Uhlemann AC, McGready R, Ashley EA, Brockman A, Singhasivanon P, et al. Intrahost selection of Plasmodium falciparum pfmdr1 alleles after antimalarial treatment on the northwestern border of Thailand. J Infect Dis 2007;195:134-1 i.org/10.1086/509809">CrossRef
25. Alker A, Lim P, Sem R, Shah N, Yi P, et al. Pfmdr1 and in vivo resistance to artesunate-mefloquine in falciparum malaria on the Cambodian-Thai border. Am J Trop Med Hyg 2007;76:641-
26. Falade CO, Salako LA, Sowunmi A, Oduola AM, Larcier P. Comparative efficacy of halofantrine, chloroquine and sulfadoxine-pyrimethamine for treatment of acute uncomplicated falciparum malaria in Nigerian children. Trans R Soc Trop Med Hyg 1997;91:58-2 i.org/10.1016/S0035-9203(97)90397-7">CrossRef
27. Happi CT, Gbotosho GO, Folarin OA, Akinboye DO, Yusuf BO, et al. Polymorphisms in Plasmodium falciparum dhfr and dhps genes and age related in vivo sulfadoxine-pyrimethamine resistance in malaria-infected patients from Nigeria. Acta Trop 2005;95:183-3 i.org/10.1016/j.actatropica.2005.06.015">CrossRef
28. Bates SJ, Winstanley PA, Watkins WM, Alloueche A, Bwika J, et al. Rare, highly pyrimethamine-resistant alleles of the Plasmodium falciparum dihydrofolate reductase gene from 5 African sites. J Infect Dis 2004;190:1783-2 i.org/10.1086/425078">CrossRef
29. Basco LK. Molecular epidemiology of malaria in Cameroon. XIII. Analysis of pfcrt mutations and in vitro chloroquine resistance. Am J Trop Med Hyg 2002;67:388-1
30. Binder RK, Borrmann S, Adegnika AA, Missinou MA, Kremsner PG, et al. Polymorphisms in the parasite genes for pfcrt and pfmdr-1 as molecular markers for chloroquine resistance in Plasmodium falciparum in Lambarene, Gabon. Parasitol Res 2002;88:475- i.org/10.1007/s00436-001-0546-7">CrossRef
31. Wilson PE, Kazadi W, Kamwendo DD, Mwapasa V, Purfield A, et al. Prevalence of pfcrt mutations in Congolese and Malawian Plasmodium falciparum isolates as determined by a new Taqman assay. Acta Trop 2005;93:97-06 i.org/10.1016/j.actatropica.2004.09.010">CrossRef
32. Happi CT, Gbotosho GO, Folarin OA, Bolaji OM, Sowunmi A, et al. Association between mutations in Plasmodium falciparum chloroquine resistance transporter and P. falciparum multidrug resistance 1 genes and in vivo amodiaquine resistance in P. falciparum malaria-infected children in Nigeria. Am J Trop Med Hyg 2006;75:155-1
33. Alifrangis M, Dalgaard MB, Lusingu JP, Vestergaard LS, Staalsoe T, et al. Occurrence of the Southeast Asian/South American SVMNT haplotype of the chloroquine-resistance transporter gene in Plasmodium falciparum in Tanzania. J Infect Dis 2006;193:1738-1 i.org/10.1086/504269">CrossRef
34. Mittra P, Vinayak S, Chandawat H, Das MK, Singh N, et al. Progressive increase in point mutations associated with chloroquine resistance in Plasmodium falciparum isolates from India. J Infect Dis 2006;193:1304-2 i.org/10.1086/502979">CrossRef
35. FMOH (2005) National guidelines and strategies for malaria prevention and control during pregnancy. A publication of the Federal Ministry of Health, Nigeria; Malaria Control Programme Abuja: FMOH
36. White NJ. Antimalarial drug resistance. J Clin Invest 2004;113:1084-2 - 作者单位：Olusola Ojurongbe (1) (2)
Segun I. Oyedeji (2) (4)
Wellington A. Oyibo (3)
Adetola F. Fagbenro-Beyioku (3)
Jürgen F. Kun (1)
1. Institute of Tropical Medicine, University of Tübingen, Tübingen, Germany
2. Department of Medical Microbiology & Parasitology College of Health Sciences, Ladoke Akintola University of Technology, Osogbo, Nigeria
4. Department of Biotechnology, Bells University, Sango Ota, Nigeria
3. Department of Medical Microbiology and Parasitology College of Medicine, University of Lagos, Lagos, Nigeria
文摘